Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Could Increase Access To Non-Pharmacological Pain Treatments, US Congress Report Says

Executive Summary

A majority of providers, payers, device companies and others with a stake in opioid treatment and substance use disorder surveyed by lawmakers told the US House Ways and Means Committee that public insurers such as Medicare need to increase access to non-pharmacological and non-opioid treatments for pain, according to a congressional whitepaper on opioids.

Advertisement

Related Content

Pay Reforms Proposed For Device Procedures At Surgical Centers
Medtech Tools To Help Address Opioid Crisis Face Reimbursement Challenges

Topics

Advertisement
UsernamePublicRestriction

Register

MT122511

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel